[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
JAMA Network Home
JAMA Neurology
Sign In

New Online

Current Issue Past Issues

Year

Day

2022
December November October September
December 5, 2022
Editorial

Hearing Aids and Cochlear Implants in the Prevention of Cognitive Decline and Dementia—Breaking Through the Silence

Michael W. Denham, MPhil; Rachel E. Weitzman, MD, MPH, MS; Justin S. Golub, MD, MS
Abstract Full Text
JAMA Neurol. Published online December 5, 2022. doi:10.1001/jamaneurol.2022.4155
Original Investigation

Association Between Consumption of Ultraprocessed Foods and Cognitive Decline

Natalia Gomes Gonçalves, PhD; Naomi Vidal Ferreira, PhD; Neha Khandpur, ScD; et al.
Abstract Full Text
JAMA Neurol. Published online December 5, 2022. doi:10.1001/jamaneurol.2022.4397

This cohort study investigates the association between ultraprocessed food consumption and cognitive decline in the Brazilian Longitudinal Study of Adult Health.

Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis

Brian Sheng Yep Yeo, MBBS; Harris Jun Jie Muhammad Danial Song, MBBS; Emma Min Shuen Toh, MBBS; et al.
Abstract Full Text
JAMA Neurol. Published online December 5, 2022. doi:10.1001/jamaneurol.2022.4427

This systematic review and meta-analysis evaluates data for patients with hearing loss from studies of the association of hearing interventions with cognitive function, cognitive decline, cognitive impairment, and dementia.

Research Letter

In Vivo N-Methyl-d-Aspartate Receptor (NMDAR) Density as Assessed Using Positron Emission Tomography During Recovery From NMDAR-Antibody Encephalitis

Marian Galovic, MD, PhD; Adam Al-Diwani, BMBCh, DPhil; Umesh Vivekananda, MD, PhD; et al.
Abstract Full Text
JAMA Neurol. Published online December 5, 2022. doi:10.1001/jamaneurol.2022.4352

This case-control study uses a radiotracer and positron emission tomography to assess N-methyl-d-aspartate receptor (NMDAR) density changes during recovery from NMDAR-antibody encephalitis.

Latest Issue

The Current Status of Next-Generation Sequencing for Diagnosis of Central Nervous System Infections
Viewpoint | November 1, 2022
What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?
Viewpoint | November 1, 2022
Seeing Ellen and the Platinum Rule
On the Brain | November 1, 2022
View More
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy